Table 2.
Within-group results at baseline and after completion of an interdisciplinary multimodal pain rehabilitation (IMPR) program, and at 12-month follow-up (FU).
| Mean Within-Subject Change and Effect Size | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline Mean (SD) | Post-IMPR Mean (SD) | 12-Month FU Mean (SD) | Baseline to PostIMPR * | 95% CI | ES | Baseline to 12 Month FU * | 95% CI | ES | |
| SF-36 PCS (0–100) | 28.5 (7.8) | 30.8 (8.7) | 31.7 (9.6) | 2.0 | 1.7–2.3 | 0.28 | 2.8 | 2.4–3.2 | 0.37 |
| SF-36 MCS (0–100) | 34.6 (12.7) | 39.1 (13.0) | 38.7 (13.3) | 4.3 | 3.8–4.9 | 0.35 | 3.8 | 3.1–4.4 | 0.32 |
| Pain intensity last 7 days (NRS) (0–10) | 7.0 (1.6) | 6.1 (1.9) | 6.0 (2.1) | −0.8 | −0.9–−0.7 | −0.51 | −0.9 | 1.0–−0.8 | −0.54 |
| EQ-5D index (−0.594–1) | 0.24 (0.30) | 0.36 (0.32) | 0.40 (0.34) | 0.11 | 0.10–0.12 | 0.39 | 0.14 | 0.12–0.15 | 0.50 |
| HADS A (0–21) | 9.5 (4.8) | 8.0 (4.5) | 7.9 (4.8) | −1.4 | −1.6–−1.2 | −0.32 | −1.3 | −1.5–−1.1 | −0.33 |
| HADS D (0–21) | 8.8 (4.4) | 6.6 (4.2) | 7.1 (4.6) | −2.2 | −2.3–−2.0 | −0.51 | −1.6 | −1.8–1.4 | −0.38 |
| MPI Impairment (0–6) | 4.0 (0.8) | 3.4 (0.9) | 3.4 (1.1) | −0.5 | −0.6–−0.5 | −0.70 | −0.5 | −0.6–−0.5 | −0.62 |
| MPI Social Support (0–6) | 3.5 (1.0) | 3.4 (1.0) | 3.4 (1.0) | −0.1 | −0.1–0.0 | 0.10 | −0.1 | −0.2–−0.1 | −0.10 |
* All parameters reached significance level <0.01, FU = Follow-up, SF 36 = 36-Item Short Form Survey, MCS = Mental Component Summary, PCS = Physical Component Summary, NRS = Numeric Rating Scale, EQ-5D = EuroQol five dimension scale, HADS A = Hospital Anxiety and Depression Scale (Anxiety), HADS D = Hospital Anxiety and Depression Scale (Depression), MPI = Multidimensional Pain Inventory. SD = Standard deviation, 95% CI = 95% Confidence Interval, ES = Effect size.